SFES · Safeguard Scientifics Inc
Market Cap
$7.86M
Shares
16.72M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$34.84M
FY2009
Net Income
-$9.83M
+31.1%
FY2023
Gross Margin
60.36%
FY2009
Operating Margin
-46.46%
FY2009
Diluted EPS
-$0.61
+29.9%
FY2023
Operating Cash Flow
-$3.31M
-1.5%
FY2023
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $34.84M | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $13.81M | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $21.03M | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 60.36% | |
| — | $5.68M | $4.78M | $7.15M | $9.47M | $9.98M | $16.87M | $17.13M | $18.69M | $17.55M | $18.97M | $21.64M | $19.47M | $21.17M | $20.85M | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | $21.17M | $20.85M | $37.21M | |
| — | — | — | — | $0 | $808K | $692K | $322K | $328K | $190K | $74K | $92K | $108K | $124K | $121K | $1.43M | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | $21.17M | $20.85M | $51.03M | |
| — | -$5.68M | -$4.78M | -$7.15M | -$9.47M | -$9.98M | -$16.87M | -$17.13M | -$18.69M | -$17.55M | -$18.97M | -$21.64M | -$19.47M | -$21.17M | -$20.85M | -$16.19M | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -46.46% | |
| — | — | — | — | -$9.47M | -$9.17M | -$16.18M | -$16.81M | -$18.36M | -$17.36M | -$18.9M | -$21.55M | -$19.37M | -$21.04M | -$20.73M | -$14.76M | |
| — | $903K | $794K | $276K | $261K | $2.04M | $2.81M | $3.88M | $2.08M | $1.94M | $1.9M | $2.65M | $2.93M | $1.42M | $718K | $480K | |
| — | $2.04M | -$3.3M | $22.04M | -$7.71M | $12.26M | -$5.16M | -$339K | -$1.68M | $217K | $31.66M | $383K | $9.34M | -$6.15M | $74.81M | $108.88M | |
| — | -$7.09M | -$6.99M | $11.85M | -$20.7M | $64.27M | $19.66M | -$66.36M | $671K | -$39.6M | -$15.34M | -$12.61M | -$26.52M | $142.46M | -$22.33M | -$23.23M | |
| — | -$9.83M | -$14.26M | $27M | -$37.62M | $54.56M | -$15.63M | -$88.57M | -$22.26M | -$59.52M | -$5.15M | -$35.53M | -$39.36M | $110.6M | $26.61M | $66.78M | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | -$14K | |
| — | -$9.83M | -$14.26M | $27M | -$37.62M | $54.56M | -$15.63M | -$88.57M | -$22.26M | -$59.52M | -$5.15M | -$35.53M | -$39.36M | $110.6M | $26.61M | $67.61M | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 194.06% | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $1.16M | |
| -$51.07M | — | — | — | — | — | — | — | — | — | -$5.15M | -$35.53M | -$39.32M | $97.74M | — | — | |
| USD/shares | — | -$0.61 | -$0.87 | $1.36 | -$1.81 | $2.64 | -$0.76 | -$4.34 | -$1.09 | -$2.85 | -$0.25 | -$1.66 | -$1.88 | $5.33 | $1.30 | $3.33 |
| USD/shares | — | -$0.61 | -$0.87 | $1.36 | -$1.81 | $2.64 | -$0.76 | -$4.34 | -$1.09 | -$2.85 | -$0.25 | -$1.66 | -$1.88 | $4.74 | $1.24 | $3.14 |
| shares | — | 16.22M | 16.34M | 19.83M | 20.75M | 20.64M | 20.54M | 20.43M | 20.34M | 20.87M | 20.98M | 21.36M | 20.97M | 20.76M | 20.54M | 20.31M |
| shares | — | 16.22M | 16.34M | 19.83M | 20.75M | 20.64M | 20.54M | 20.43M | 20.34M | 20.87M | 20.98M | 21.36M | 20.97M | 24.52M | 21.51M | 22.38M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2009–FY2023: $79.26M in buybacks, $26.5M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.